Riboflavin mutants as vaccines against actinobacillus...

Details Riboflavin mutants as vaccines against actinobacillus... Riboflavin mutants as vaccines against actinobacillus...

A - Human Necessities

61

K

A61K 39/102 (2006.01) C12N 1/21 (2006.01) C12N 1/36 (2006.01) C12N 15/52 (2006.01) C12N 15/74 (2006.01)

Patent

CA 2241626

Described is a vaccine against Actinobacillus pleuropneumoniae (APP) comprising genetically defined biochemically attenuated mutant of APP that requires riboflavin and is attenuated in vivo.

L'invention concerne un vaccin contre actinobacillus pleuropneumoniae (APP), comprenant un mutant d'APP atténué d'un point de vue biochimique, qui nécessite la riboflavine et est atténué in vivo.

Affiliated with

Also associated with

Rating

Riboflavin mutants as vaccines against actinobacillus... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Riboflavin mutants as vaccines against actinobacillus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Riboflavin mutants as vaccines against actinobacillus... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1604934